Kolon TissueGene (950160) exhibited volatility on the 7th, dropping to as low as 16,250 won during the session, but managed to recover its losses and close higher as buying interest flowed in.

On this day, Kolon TissueGene finished trading at 17,660 won, up 90 won (0.51%) from the previous trading day. Ahead of the weekend, the stock experienced weakness, slipping to the low 16,000-won range, but successfully rebounded to end nearly flat.

On the same day, both the KOSPI and KOSDAQ closed lower, falling 0.59% and 0.35% respectively. Against this backdrop, Kolon TissueGene maintained positive territory, showing a relatively steady trend.

However, given the large intraday volatility, supply and demand changes and investor sentiment are expected to influence the stock price in the short term, with attention also focused on the trajectory of the new drug submission. Investors are also paying close attention to how shifts in global investor sentiment may impact domestic biotech stocks overall next week.

[※ This article is not intended to solicit investment, and all investment decisions and responsibilities lie with the investor.]